MDMA (ecstasy) effects in pubescent rats: Males are more sensitive than females
- PMID: 15951008
- DOI: 10.1016/j.pbb.2005.04.014
MDMA (ecstasy) effects in pubescent rats: Males are more sensitive than females
Abstract
In Experiment 1, we assessed the effects of 3,4-methylenedioxymethamphetamine (MDMA) on locomotor activity in pubescent male and female Long-Evans rats. Thirty-nine day old rats were injected ip with 10 mg/kg of MDMA (ambient temperature 25 degrees C) three times at 2 h intervals. Initially, females showed greater locomotor activation by the drug than males, however after the second injection, males showed greater hyperlocomotion. After the third injection, 3 of 10 females and all of the males died. In the surviving females, we observed serotonin depletion in cortex and hippocampus, but catecholaminergic markers were unaltered. In Experiment 2, male and female rats were repeatedly injected with saline or 2, 5 or 10 mg/kg MDMA and body temperature was measured (ambient temperature 21.5 degrees C). After the third injection of 10 mg/kg MDMA, the MDMA-induced hyperthermia was greater in males than in females (about +0.8 degrees C); at the lower dose, no difference was observed. Probably because of the lower ambient temperature, only 1 female and 2 males succumbed to the MDMA treatment, and MDMA induced less serotonin depletion than in the first experiment, with no difference between females and males. Thus, pubescent males appear to be more sensitive than females to locomotor and hyperpyretic effects of MDMA. This sex-dependent effect, which is at variance with previously reported dimorphisms in psychostimulant effects, is discussed in terms of possible differences in dopamine D1 and D2 receptors at pubescence, or other factors related to drug metabolism.
Similar articles
-
Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.J Psychopharmacol. 2004 Sep;18(3):412-6. doi: 10.1177/026988110401800312. J Psychopharmacol. 2004. PMID: 15358986
-
Increased effects of 3,4-methylenedioxymethamphetamine (ecstasy) in a rat model of depression.Addict Biol. 2011 Jan;16(1):7-19. doi: 10.1111/j.1369-1600.2009.00196.x. Addict Biol. 2011. PMID: 20192951
-
Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").Neuropharmacology. 2006 Jan;50(1):69-80. doi: 10.1016/j.neuropharm.2005.08.006. Epub 2005 Sep 26. Neuropharmacology. 2006. PMID: 16188283
-
Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)?Neurosci Biobehav Rev. 2007;31(3):327-47. doi: 10.1016/j.neubiorev.2006.09.009. Epub 2006 Nov 15. Neurosci Biobehav Rev. 2007. PMID: 17109962 Review.
-
Ecstasy: are animal data consistent between species and can they translate to humans?J Psychopharmacol. 2006 Mar;20(2):194-210. doi: 10.1177/0269881106061153. J Psychopharmacol. 2006. PMID: 16510478 Review.
Cited by
-
Sex Differences in Neurotoxicogenetics.Front Genet. 2018 Jun 5;9:196. doi: 10.3389/fgene.2018.00196. eCollection 2018. Front Genet. 2018. PMID: 29922331 Free PMC article. Review.
-
Monoamine oxidase-B mediates ecstasy-induced neurotoxic effects to adolescent rat brain mitochondria.J Neurosci. 2007 Sep 19;27(38):10203-10. doi: 10.1523/JNEUROSCI.2645-07.2007. J Neurosci. 2007. PMID: 17881526 Free PMC article.
-
Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.Mol Neurobiol. 2009 Jun;39(3):210-71. doi: 10.1007/s12035-009-8064-1. Epub 2009 Apr 17. Mol Neurobiol. 2009. PMID: 19373443 Review.
-
Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder.Psychedelic Med (New Rochelle). 2023 Sep 13;1(3):166-185. doi: 10.1089/psymed.2023.0023. eCollection 2023 Sep. Psychedelic Med (New Rochelle). 2023. PMID: 40046567 Free PMC article. Review.
-
Acute and Subchronic Toxicity Profile of a Polyherbal Drug Used in Sri Lankan Traditional Medicine.Evid Based Complement Alternat Med. 2020 Jul 13;2020:2189189. doi: 10.1155/2020/2189189. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32765627 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical